跳至主要内容
临床试验/NCT04347187
NCT04347187招募中不适用

Registry Dedicated to Assess the Risk of Ischemic and Hemorrhagic Complications of Long-term Antithrombotic Therapy in Patients With Atrial Fibrillation

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation2 个研究点 分布在 2 个国家目标入组 2,000 人开始时间: 2015年1月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2,000
试验地点
2
主要终点
composite of any bleeding events

研究概览

简要总结

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with atrial fibrillation

详细描述

The register is a Russian prospective single-center observational study of patients who have indications for long-term antithrombotic therapy in connection with atrial fibrillation

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Documented atrial fibrillation with CHA2DS2VASC > 1

排除标准

  • Subjects who are unwilling or unable to provide informed consent. ACS within 12 months before inclusion Severe CHF (NYHA IV) Stroke within 6 months before inclusion Severe liver or muscle disease Severe kidney disease / renal failure with creatinine > 3 mg/dl Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention

结局指标

主要结局

composite of any bleeding events

时间窗: unclusion up to 5 years

major, clinically relevant nonmajor, minor (BARC, ISTH,GARFIELD AF)

composite of major cardiovascular events

时间窗: unclusion up to 5 years

stroke, myocardial infarction, stent thrombosis \[definite or probable\], or urgent revascularization, cqrdiac death

次要结局

  • Mutations in following genes(inclusion)

研究者

发起方
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验